Skip to search.
 Dow Down 0.60% Nasdaq Down 0.07%

STAAR Surgical Company (STAA)

-NasdaqGM

8.86 Up 0.06(0.68%) May 25, 4:00PM EDT|After Hours: 8.86 0.00 (0.00%) May 25, 4:48PM EDT

ProfileGet Profile for:
STAAR Surgical Company
1911 Walker Avenue
Monrovia, CA 91016
United States - Map
Phone: 626-303-7902
Fax: 626-303-2962
Website: http://www.staar.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Medical Instruments & Supplies
Full Time Employees:297

Business Summary 

STAAR Surgical Company, together with its subsidiaries, engages in the design, development, manufacture, and sale of implantable lenses for the cataracts and refractive surgery. It offers intraocular lenses (IOL) that include silicone Toric IOL, which is used in cataract surgery to treat preexisting astigmatism; Preloaded Injector, a three-piece silicone or acrylic IOL preloaded into a single-use disposable injector; Aspheric IOLs that provide a clearer image than traditional spherical IOLs; and nanoFLEX IOL, a single-piece collamer aspheric IOL. The company also provides implantable collamer lenses (ICL) comprising VISIAN ICL and VISIAN Toric ICL to treat refractive disorders, such as myopia, hyperopia, and astigmatism. In addition, it sells surgical products and other related instruments, as well as manufactures AquaFlow device for the treatment of glaucoma. The company markets its products to health care providers, including surgical centers, hospitals, managed care providers, health maintenance organizations, group purchasing organizations, and government facilities primarily under the STAAR, Visian, Collamer, nanoFLEX, nanoPOINT, CentraFLOW, AquaPORT, Epiphany, and AquaFlow names. It distributes its products through directly employed representatives, independent sales representatives, and local distributors in the United States and internationally. The company was founded in 1982 and is headquartered in Monrovia, California.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on STAAR Surgical Company

Corporate Governance 
STAAR Surgical Company’s Governance Risk Indicator (GRI®) as of May 1, 2012 is: Audit (Medium Concern), Board (Low Concern), Compensation (Medium Concern), Shareholder Rights (Medium Concern).
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
 PayExercised
Mr. Barry G. Caldwell , 61
Chief Exec. Officer, Pres and Director
789.00K0.00
Ms. Deborah Andrews , 55
Chief Financial Officer, Principal Accounting Officer and VP
389.00K0.00
Mr. Robin Hughes , 48
VP of Global Marketing
377.00K0.00
Mr. Hans-Martin Blickensdoerfer , 46
Pres of Europe, Middle East, Africa and Latin America
435.00K0.00
Mr. Philippe Subrin , 48
VP of Switzerland Operations
359.00K0.00
Amounts are as of Dec 30, 2011 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders